Internship

Machine Learning Ops Intern

Confirmed live in the last 24 hours

Resmed

Resmed

5,001-10,000 employees

Develops cloud-connected medical devices for chronic diseases

Compensation Overview

$22.50 - $41.50/hr

No H1B Sponsorship

San Diego, CA, USA

This is preferred to be a hybrid role located at our ResMed headquarters in San Diego, CA. Candidates will be asked to be available to participate in on-site team meetings.

Category
Applied Machine Learning
AI & Machine Learning
Operations & Logistics
Required Skills
Kubernetes
Python
Git
SQL
Docker
AWS
Pandas
Terraform
Requirements
  • Ability to work full-time for 12 weeks during Summer 2025; program dates are May 19, 2025 – August 8, 2025 OR June 16, 2025 – September 5, 2025
  • Computer Science or Machine Learning academic studies that will lead to a Bachelor's or Master's Degree
  • Experience or self study in Python, SQL, Pandas, AWS, Terraform, Docker, Github, general CI/CD practices
Responsibilities
  • Build automation and leading-edge architecture around Data and AI/ML engineering on an AWS & Kubernetes platform
  • Code and help architect a production-grade, scalable platform to be used by dozens of data scientists
Desired Qualifications
  • Excellent critical thinking and problem-solving skills.
  • Strong experiences as demonstrated through projects, research or Computer-Science/Machine-Learning internships
  • Great interpersonal relations, team cooperation and communication skills.
  • Exceptional organizational and collaboration skills as demonstrated through leadership positions on teams and/or in student or civic organizations
  • Exceptional communication skills and interest and enthusiasm related to medical technology industry and a career with ResMed

ResMed develops medical devices and software platforms that help treat and manage conditions like sleep apnea and chronic obstructive pulmonary disease (COPD). Their products are cloud-connected, allowing for better monitoring and management of patients' health. ResMed serves patients, healthcare professionals, and caregivers, focusing on improving care and quality of life. Unlike many competitors, ResMed combines device sales with software subscriptions, creating a recurring revenue model. The company's goal is to reduce hospital visits and lower healthcare costs while providing effective solutions for chronic disease management.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing telemedicine adoption boosts demand for ResMed's cloud-connected devices.
  • The sleep apnea devices market is projected to grow at a 7.8% CAGR until 2030.
  • AI integration in healthcare enhances ResMed's diagnostic accuracy and patient outcomes.

What critics are saying

  • Emerging wearable tech companies threaten ResMed's market share in sleep apnea diagnostics.
  • Global chip shortage may delay ResMed's product launches and impact revenue.
  • Cybersecurity breaches in healthcare pose risks to ResMed's data security.

What makes Resmed unique

  • ResMed offers cloud-connected devices for sleep apnea and COPD management.
  • The company provides software platforms enhancing patient care and reducing healthcare costs.
  • ResMed operates in over 120 countries, ensuring a global reach and market presence.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

Employee Assistance Program (EAP)

Company News

IR Impact
Apr 24th, 2025
Resmed names Salli Schwartz as chief investor relations officer

Healthcare technology provider Resmed has named Salli Schwartz as its chief investor relations officer.

Veye
Apr 24th, 2025
Top ASX Stocks Get a Lift Post Strong Quarters

ResMed was also recognized as one of LexisNexis "Top 100 Global Innovators."

Fierce Biotech
Apr 4th, 2025
Resmed debuts wearable, at-home sleep apnea test

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.

Medtrade
Apr 4th, 2025
Resmed Launches New Home Sleep Apnea Test

SAN DIEGO - Medtrade exhibitor Resmed has launched NightOwl(TM), a new home sleep apnea test (HSAT) that is now available across the United States.

MPO Magazine
Apr 3rd, 2025
Resmed Launches NightOwl Home Sleep Apnea Test

Resmed has launched its NightOwl home sleep apnea test (HSAT) in the U.S.